MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Akbar, M.
Right arrow Articles by Kondo, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akbar, M.
Right arrow Articles by Kondo, Y.

A single species of A1 adenosine receptor expressed in Chinese hamster ovary cells not only inhibits cAMP accumulation but also stimulates phospholipase C and arachidonate release

M Akbar, F Okajima, H Tomura, S Shimegi and Y Kondo

Department of Physical Biochemistry, Gunma University, Maebashi, Japan.

Chinese hamster ovary cells were transfected with both A1 adenosine receptor and muscarinic type 3 acetylcholine receptor cDNAs. The muscarinic receptor agonist carbachol stimulated phospholipase C activity, resulting in Ca2+ mobilization and arachidonate release. N6- Cyclopentyladenosine (CPA), an A1 receptor agonist, did not activate Ca(2+)-related signal transduction systems by itself but instead inhibited cAMP accumulation. In the presence of carbachol, however, the A1 receptor agonist enhanced muscarinic receptor agonist-induced phospholipase C/Ca2+ responses. In addition, the arachidonate release caused by Ca2+ ionophores or thapsigargin was also amplified by CPA, without a change in phospholipase C activity. Thus, CPA augments Ca(2+)- mediated phospholipase A2 activation in addition to and separate from its ability to amplify phospholipase C-mediated Ca2+ mobilization. Because the permissive actions of CPA on phospholipase C and phospholipase A2 activation were each reversed by pertussis toxin treatment, in a manner similar to that of the CPA-induced inhibition of cAMP accumulation, we conclude that a single species of A1 receptor expressed in Chinese hamster ovary cells can couple to multiple signal transduction systems stemming from phospholipase C stimulation, phospholipase A2-mediated and Ca(2+)-dependent arachidonate release, and inhibition of cAMP accumulation. A pertussis toxin-sensitive G protein (or proteins) mediates the permissive actions of the A1 receptor in the stimulation of phospholipase C- and phospholipase A2- mediated arachidonate release.

Volume 45, Issue 5, pp. 1036-1042, 05/01/1994
Copyright © 1994 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S.-H. Hsu and C.-W. Luo
Molecular dissection of G protein preference using Gs{alpha} chimeras reveals novel ligand signaling of GPCRs
Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1021 - E1029.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Z. Guan, D. A. Osmond, and E. W. Inscho
Purinoceptors in the Kidney
Experimental Biology and Medicine, June 1, 2007; 232(6): 715 - 726.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. J. Ray and J. M. Marshall
The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium
J. Physiol., January 1, 2006; 570(1): 85 - 96.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J F Kinsel and M V Sitkovsky
Possible targeting of G protein coupled receptors to manipulate inflammation in vivo using synthetic and natural ligands
Ann Rheum Dis, November 1, 2003; 62(90002): ii22 - 24.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
C. Neely Wilson and V. K. Batra
Lipopolysaccharide binds to and activates A1 adenosine receptors on human pulmonary artery endothelial cells
Innate Immunity, August 1, 2002; 8(4): 263 - 271.
[Abstract] [PDF]


Home page
Pharmacol. Rev.Home page
B. B. Fredholm, A. P. IJzerman, K. A. Jacobson, K.-N. Klotz, and J. Linden
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Pharmacol. Rev., December 1, 2001; 53(4): 527 - 552.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Tomura, H. Itoh, K. Sho, K. Sato, M. Nagao, M. Ui, Y. Kondo, and F. Okajima
beta gamma Subunits of Pertussis Toxin-sensitive G Proteins Mediate A1 Adenosine Receptor Agonist-induced Activation of Phospholipase C in Collaboration with Thyrotropin. A NOVEL STIMULATORY MECHANISM THROUGH THE CROSS-TALK OF TWO TYPES OF RECEPTORS
J. Biol. Chem., September 12, 1997; 272(37): 23130 - 23137.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. Biber, K.-N. Klotz, M. Berger, P. J. Gebicke-Harter, and D. van Calker
Adenosine A1 Receptor-Mediated Activation of Phospholipase C in Cultured Astrocytes Depends on the Level of Receptor Expression
J. Neurosci., July 1, 1997; 17(13): 4956 - 4964.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Godson and S. M. Reppert
The Mel1a Melatonin Receptor Is Coupled to Parallel Signal Transduction Pathways
Endocrinology, January 1, 1997; 138(1): 397 - 404.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1994 by the American Society for Pharmacology and Experimental Therapeutics